English

SYNOVIS LIFE TECHNOLOGIES INC

EDGAR

Annual report (10-K) · filed 2012-01-06

68 filing records in this dataset, filed from 1995-08-29 to 2012-01-06. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

21 million USD

2011-07-31 · USD

Exact inputs and evidence

Revenue: 21017000 USD Source

Cash and cash equivalents: 18 million U001 2011-10-31 Source
Exact value

18013000 U001
Long-term debt including current maturities: Not available
Shares outstanding: 11.2 million U003 2011-10-31 Source
Exact value

11167690 U003

Reported share-count change

-0.54% · -61 thousand U003

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

11228654 U003 · 2010-10-31· Source
11167690 U003 · 2011-10-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

78.4 million USD

2010-08-01 – 2011-07-31

Exact inputs and evidence

Revenue: 68565000 USD · 2009-11-01 – 2010-10-31 Source
Revenue: 50449000 USD · 2009-11-01 – 2010-07-31 Source
Revenue: 19477000 USD · 2010-11-01 – 2011-01-31 Source
Revenue: 19816000 USD · 2011-02-01 – 2011-04-30 Source
Revenue: 21017000 USD · 2011-05-01 – 2011-07-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-01-06.

Financial data available through: 2010-10-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2010-10-31
Operating income: 2 of 11 periods available· newest 2010-10-31
Net income: 2 of 11 periods available· newest 2010-10-31
Operating cash flow: 2 of 11 periods available· newest 2010-10-31
Capital expenditure: 2 of 11 periods available· newest 2010-10-31
Total assets: 1 of 11 periods available· newest 2010-10-31
Total liabilities: 1 of 11 periods available· newest 2010-10-31
Current assets: 1 of 11 periods available· newest 2010-10-31
Current liabilities: 1 of 11 periods available· newest 2010-10-31
Cash and cash equivalents: 3 of 11 periods available· newest 2010-10-31
long term debt: No compatible figures in this window
Shares outstanding: 1 of 11 periods available· newest 2010-10-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+17.8%

Prior period

USD 58.21 million

2008-11-01 – 2009-10-31
Current period

USD 68.57 million

2009-11-01 – 2010-10-31

Exact inputs and evidence

68565000 − 58211000 = 10354000 USD

58211000 USD · 2008-11-01 – 2009-10-31
Inspect prior input Prior source
68565000 USD · 2009-11-01 – 2010-10-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SYNOVIS LIFE TECHNOLOGIES INC · 2010-10-31 SYNOVIS LIFE TECHNOLOGIES INC (edgar:780127) Year-over-year change in Revenue: 10354000 USD Concept: fundies:Revenue Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T18:08:28Z Snapshot: 492f88e2339bfab9f8e0316f2318ad6f7a63b105a14634eeba87ebacddcb839c Dimensions: Consolidated View: https://fundies.io/companies/edgar/780127?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 68565000 USD (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/780127/0000950123-11-000689.txt#11951 Input fundies:Revenue: 58211000 USD (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/780127/0000950123-11-000689.txt#11951
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income, Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2009-11-01 – 2010-10-31

Revenue USD 68.57 million 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 Not shown: operating income or net income is not reported.
2002 Not shown: operating income or net income is not reported.
2003 Not shown: operating income or net income is not reported.
2004 Not shown: operating income or net income is not reported.
2005 Not shown: operating income or net income is not reported.
2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.
2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.
2010 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2000-11-01 – 2001-10-31	28535000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2000-11-01 – 2001-10-31: 28535000 USD Inspect Revenue Open source
2002 2001-11-01 – 2002-10-31	39962000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2001-11-01 – 2002-10-31: 39962000 USD Inspect Revenue Open source
2003 2002-11-01 – 2003-10-31	57989000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2002-11-01 – 2003-10-31: 57989000 USD Inspect Revenue Open source
2004 2003-11-01 – 2004-10-31	55044000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2003-11-01 – 2004-10-31: 55044000 USD Inspect Revenue Open source
2005 2004-11-01 – 2005-10-31	60256000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2004-11-01 – 2005-10-31: 60256000 USD Inspect Revenue Open source
2006 2005-11-01 – 2006-10-31	27743000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2005-11-01 – 2006-10-31: 27743000 USD Inspect Revenue Open source
2007 2006-11-01 – 2007-10-31	37691000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2006-11-01 – 2007-10-31: 37691000 USD Inspect Revenue Open source
2008 2007-11-01 – 2008-10-31	49800000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2007-11-01 – 2008-10-31: 49800000 USD Inspect Revenue Open source
2009 2008-11-01 – 2009-10-31	58211000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2008-11-01 – 2009-10-31: 58211000 USD Inspect Revenue Open source
2010 2009-11-01 – 2010-10-31	68565000	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2009-11-01 – 2010-10-31: 68565000 USD Inspect Revenue Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 68.6M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-10-31	Revenue	28535000	Revenue: 28535000 Open source
20022002-10-31	Revenue	39962000	Revenue: 39962000 Open source
20032003-10-31	Revenue	57989000	Revenue: 57989000 Open source
20042004-10-31	Revenue	55044000	Revenue: 55044000 Open source
20052005-10-31	Revenue	60256000	Revenue: 60256000 Open source
20062006-10-31	Revenue	27743000	Revenue: 27743000 Open source
20072007-10-31	Revenue	37691000	Revenue: 37691000 Open source
20082008-10-31	Revenue	49800000	Revenue: 49800000 Open source
20092009-10-31	Revenue	58211000	Revenue: 58211000 Open source
20102010-10-31	Revenue	68565000	Revenue: 68565000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

17.8% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-10-31	Year over year	29.1%	Revenue: 28535000 Open source Revenue: 22098000 Open source
20022002-10-31	Year over year	40%	Revenue: 39962000 Open source Revenue: 28535000 Open source
20032003-10-31	Year over year	45.1%	Revenue: 57989000 Open source Revenue: 39962000 Open source
20042004-10-31	Year over year	-5.1%	Revenue: 55044000 Open source Revenue: 57989000 Open source
20052005-10-31	Year over year	9.5%	Revenue: 60256000 Open source Revenue: 55044000 Open source
20062006-10-31	Year over year	-54%	Revenue: 27743000 Open source Revenue: 60256000 Open source
20072007-10-31	Year over year	35.9%	Revenue: 37691000 Open source Revenue: 27743000 Open source
20082008-10-31	Year over year	32.1%	Revenue: 49800000 Open source Revenue: 37691000 Open source
20092009-10-31	Year over year	16.9%	Revenue: 58211000 Open source Revenue: 49800000 Open source
20102010-10-31	Year over year	17.8%	Revenue: 68565000 Open source Revenue: 58211000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2001-10-31	Operating margin	Not reported	Revenue: 28535000 Open source
2002-10-31	Operating margin	Not reported	Revenue: 39962000 Open source
2003-10-31	Operating margin	Not reported	Revenue: 57989000 Open source
2004-10-31	Operating margin	Not reported	Revenue: 55044000 Open source
2005-10-31	Operating margin	Not reported	Revenue: 60256000 Open source
2006-10-31	Operating margin	Not reported	Revenue: 27743000 Open source
2007-10-31	Operating margin	Not reported	Revenue: 37691000 Open source
2008-10-31	Operating margin	Not reported	Revenue: 49800000 Open source
2009-10-31	Operating margin	Not reported	Revenue: 58211000 Open source
2010-10-31	Operating margin	Not reported	Revenue: 68565000 Open source
2001-10-31	Net margin	Not reported	Revenue: 28535000 Open source
2002-10-31	Net margin	Not reported	Revenue: 39962000 Open source
2003-10-31	Net margin	Not reported	Revenue: 57989000 Open source
2004-10-31	Net margin	Not reported	Revenue: 55044000 Open source
2005-10-31	Net margin	Not reported	Revenue: 60256000 Open source
2006-10-31	Net margin	Not reported	Revenue: 27743000 Open source
2007-10-31	Net margin	Not reported	Revenue: 37691000 Open source
2008-10-31	Net margin	Not reported	Revenue: 49800000 Open source
2009-10-31	Net margin	Not reported	Revenue: 58211000 Open source
2010-10-31	Net margin	Not reported	Revenue: 68565000 Open source
20012001-10-31	Free cash flow margin	Not reported	Revenue: 28535000 Open source
20022002-10-31	Free cash flow margin	Not reported	Revenue: 39962000 Open source
20032003-10-31	Free cash flow margin	Not reported	Revenue: 57989000 Open source
20042004-10-31	Free cash flow margin	Not reported	Revenue: 55044000 Open source
20052005-10-31	Free cash flow margin	Not reported	Revenue: 60256000 Open source
20062006-10-31	Free cash flow margin	Not reported	Revenue: 27743000 Open source
20072007-10-31	Free cash flow margin	Not reported	Revenue: 37691000 Open source
20082008-10-31	Free cash flow margin	Not reported	Revenue: 49800000 Open source
20092009-10-31	Free cash flow margin	Not reported	Revenue: 58211000 Open source
20102010-10-31	Free cash flow margin	Not reported	Revenue: 68565000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-10-31	Operating cash flow	Not reported	No source recorded
20022002-10-31	Operating cash flow	Not reported	No source recorded
20032003-10-31	Operating cash flow	Not reported	No source recorded
20042004-10-31	Operating cash flow	Not reported	No source recorded
20052005-10-31	Operating cash flow	Not reported	No source recorded
20062006-10-31	Operating cash flow	Not reported	No source recorded
20072007-10-31	Operating cash flow	Not reported	No source recorded
20082008-10-31	Operating cash flow	Not reported	No source recorded
20092009-10-31	Operating cash flow	Not reported	No source recorded
20102010-10-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value	Source evidence
20012001-10-31	Free cash flow	Unavailable	No source recorded
20022002-10-31	Free cash flow	Unavailable	No source recorded
20032003-10-31	Free cash flow	Unavailable	No source recorded
20042004-10-31	Free cash flow	Unavailable	No source recorded
20052005-10-31	Free cash flow	Unavailable	No source recorded
20062006-10-31	Free cash flow	Unavailable	No source recorded
20072007-10-31	Free cash flow	Unavailable	No source recorded
20082008-10-31	Free cash flow	Unavailable	No source recorded
20092009-10-31	Free cash flow	Unavailable	No source recorded
20102010-10-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2001-10-31	Liabilities / assets	Not reported	No source recorded
2002-10-31	Liabilities / assets	Not reported	No source recorded
2003-10-31	Liabilities / assets	Not reported	No source recorded
2004-10-31	Liabilities / assets	Not reported	No source recorded
2005-10-31	Liabilities / assets	Not reported	No source recorded
2006-10-31	Liabilities / assets	Not reported	No source recorded
2007-10-31	Liabilities / assets	Not reported	No source recorded
2008-10-31	Liabilities / assets	Not reported	No source recorded
2009-10-31	Liabilities / assets	Not reported	No source recorded
2010-10-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2001-10-31	Current assets / current liabilities	Not reported	No source recorded
2002-10-31	Current assets / current liabilities	Not reported	No source recorded
2003-10-31	Current assets / current liabilities	Not reported	No source recorded
2004-10-31	Current assets / current liabilities	Not reported	No source recorded
2005-10-31	Current assets / current liabilities	Not reported	No source recorded
2006-10-31	Current assets / current liabilities	Not reported	No source recorded
2007-10-31	Current assets / current liabilities	Not reported	No source recorded
2008-10-31	Current assets / current liabilities	Not reported	No source recorded
2009-10-31	Current assets / current liabilities	Not reported	No source recorded
2010-10-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2008-11-01 – 2009-10-31	U001 2.71 million Exact value Exact value: 2706000 U001 2008-11-01 – 2009-10-31: 2706000 U001 Inspect Net Income Open source Share or cite Citation for Net Income · SYNOVIS LIFE TECHNOLOGIES INC · 2009-10-31 SYNOVIS LIFE TECHNOLOGIES INC (edgar:780127) Net Income: 2706000 U001 Concept: fundies:NetIncome Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-02T18:08:28Z Snapshot: 492f88e2339bfab9f8e0316f2318ad6f7a63b105a14634eeba87ebacddcb839c Dimensions: Consolidated View: https://fundies.io/companies/edgar/780127/explain?concept=fundies%3ANetIncome&period=2009-10-31&surface=latest&period_type=duration&start=2008-11-01&unit=U001&dimensions= Input fundies:NetIncome: 2706000 U001 (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/780127/000114036112001445/syno-20111031.xml#248078 Filing: 000114036112001445 The citation records this snapshot. The page link may show a newer release later.	U001 9.75 million Exact value Exact value: 9746000 U001 2008-11-01 – 2009-10-31: 9746000 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYNOVIS LIFE TECHNOLOGIES INC · 2009-10-31 SYNOVIS LIFE TECHNOLOGIES INC (edgar:780127) Operating Cash Flow: 9746000 U001 Concept: fundies:OperatingCashFlow Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-02T18:08:28Z Snapshot: 492f88e2339bfab9f8e0316f2318ad6f7a63b105a14634eeba87ebacddcb839c Dimensions: Consolidated View: https://fundies.io/companies/edgar/780127/explain?concept=fundies%3AOperatingCashFlow&period=2009-10-31&surface=latest&period_type=duration&start=2008-11-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: 9746000 U001 (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/780127/000114036112001445/syno-20111031.xml#247603 Filing: 000114036112001445 The citation records this snapshot. The page link may show a newer release later.	U001 1.16 million Exact value Exact value: 1156000 U001 2008-11-01 – 2009-10-31: 1156000 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYNOVIS LIFE TECHNOLOGIES INC · 2009-10-31 SYNOVIS LIFE TECHNOLOGIES INC (edgar:780127) Capital Expenditure: 1156000 U001 Concept: fundies:CapitalExpenditure Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-02T18:08:28Z Snapshot: 492f88e2339bfab9f8e0316f2318ad6f7a63b105a14634eeba87ebacddcb839c Dimensions: Consolidated View: https://fundies.io/companies/edgar/780127/explain?concept=fundies%3ACapitalExpenditure&period=2009-10-31&surface=latest&period_type=duration&start=2008-11-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 1156000 U001 (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/780127/000114036112001445/syno-20111031.xml#263944 Filing: 000114036112001445 The citation records this snapshot. The page link may show a newer release later.	U001 8.59 million Calculation and evidence 9746000 − 1156000 U001 Exact free cash flow: 8590000 U001 2008-11-01 – 2009-10-31: 9746000 U001 · Inspect Operating Cash Flow · Source 2008-11-01 – 2009-10-31: 1156000 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYNOVIS LIFE TECHNOLOGIES INC · 2009-10-31 SYNOVIS LIFE TECHNOLOGIES INC (edgar:780127) Free cash flow: 8590000 U001 Concept: free-cash-flow Period: 2008-11-01 to 2009-10-31 Values: Latest reported Published: 2026-11-02T18:08:28Z Snapshot: 492f88e2339bfab9f8e0316f2318ad6f7a63b105a14634eeba87ebacddcb839c Dimensions: Consolidated View: https://fundies.io/companies/edgar/780127?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 9746000 U001 (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/780127/000114036112001445/syno-20111031.xml#247603 Filing: 000114036112001445 Input fundies:CapitalExpenditure: 1156000 U001 (2008-11-01 to 2009-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/780127/000114036112001445/syno-20111031.xml#263944 Filing: 000114036112001445 The citation records this snapshot. The page link may show a newer release later.
2010 2009-11-01 – 2010-10-31	U001 4.88 million Exact value Exact value: 4876000 U001 2009-11-01 – 2010-10-31: 4876000 U001 Inspect Net Income Open source Share or cite Citation for Net Income · SYNOVIS LIFE TECHNOLOGIES INC · 2010-10-31 SYNOVIS LIFE TECHNOLOGIES INC (edgar:780127) Net Income: 4876000 U001 Concept: fundies:NetIncome Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T18:08:28Z Snapshot: 492f88e2339bfab9f8e0316f2318ad6f7a63b105a14634eeba87ebacddcb839c Dimensions: Consolidated View: https://fundies.io/companies/edgar/780127/explain?concept=fundies%3ANetIncome&period=2010-10-31&surface=latest&period_type=duration&start=2009-11-01&unit=U001&dimensions= Input fundies:NetIncome: 4876000 U001 (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/780127/000114036112001445/syno-20111031.xml#247939 Filing: 000114036112001445 The citation records this snapshot. The page link may show a newer release later.	U001 6.9 million Exact value Exact value: 6903000 U001 2009-11-01 – 2010-10-31: 6903000 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SYNOVIS LIFE TECHNOLOGIES INC · 2010-10-31 SYNOVIS LIFE TECHNOLOGIES INC (edgar:780127) Operating Cash Flow: 6903000 U001 Concept: fundies:OperatingCashFlow Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T18:08:28Z Snapshot: 492f88e2339bfab9f8e0316f2318ad6f7a63b105a14634eeba87ebacddcb839c Dimensions: Consolidated View: https://fundies.io/companies/edgar/780127/explain?concept=fundies%3AOperatingCashFlow&period=2010-10-31&surface=latest&period_type=duration&start=2009-11-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: 6903000 U001 (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/780127/000114036112001445/syno-20111031.xml#247365 Filing: 000114036112001445 The citation records this snapshot. The page link may show a newer release later.	U001 1.1 million Exact value Exact value: 1102000 U001 2009-11-01 – 2010-10-31: 1102000 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SYNOVIS LIFE TECHNOLOGIES INC · 2010-10-31 SYNOVIS LIFE TECHNOLOGIES INC (edgar:780127) Capital Expenditure: 1102000 U001 Concept: fundies:CapitalExpenditure Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T18:08:28Z Snapshot: 492f88e2339bfab9f8e0316f2318ad6f7a63b105a14634eeba87ebacddcb839c Dimensions: Consolidated View: https://fundies.io/companies/edgar/780127/explain?concept=fundies%3ACapitalExpenditure&period=2010-10-31&surface=latest&period_type=duration&start=2009-11-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 1102000 U001 (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/780127/000114036112001445/syno-20111031.xml#263707 Filing: 000114036112001445 The citation records this snapshot. The page link may show a newer release later.	U001 5.8 million Calculation and evidence 6903000 − 1102000 U001 Exact free cash flow: 5801000 U001 2009-11-01 – 2010-10-31: 6903000 U001 · Inspect Operating Cash Flow · Source 2009-11-01 – 2010-10-31: 1102000 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SYNOVIS LIFE TECHNOLOGIES INC · 2010-10-31 SYNOVIS LIFE TECHNOLOGIES INC (edgar:780127) Free cash flow: 5801000 U001 Concept: free-cash-flow Period: 2009-11-01 to 2010-10-31 Values: Latest reported Published: 2026-11-02T18:08:28Z Snapshot: 492f88e2339bfab9f8e0316f2318ad6f7a63b105a14634eeba87ebacddcb839c Dimensions: Consolidated View: https://fundies.io/companies/edgar/780127?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6903000 U001 (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/780127/000114036112001445/syno-20111031.xml#247365 Filing: 000114036112001445 Input fundies:CapitalExpenditure: 1102000 U001 (2009-11-01 to 2010-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/780127/000114036112001445/syno-20111031.xml#263707 Filing: 000114036112001445 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

68 filings · 253 latest values · 253 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000780127, 780127, edgar:780127

Also known as BIO VASCULAR INC, SYNOVIS LIFE TECHNOLOGIES INC, SYNOVIS LIFE TECHNOLOGIES INC

SYNOVIS LIFE TECHNOLOGIES INC

Latest quarter

Revenue

Reported share-count change

Trailing twelve months

Revenue

Company performance

What changed year over year

Revenue

Where revenue goes

2010 2009-11-01 – 2010-10-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation